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The interactions between the gut microbiota and its host are of central importance to
the health of the host. Outer membrane vesicles (OMVs) are produced ubiquitously
by Gram-negative bacteria including the gut commensal Bacteroides thetaiotaomicron.
These vesicles can interact with the host in various ways but until now their complement
of small molecules has not been investigated in this context. Using an untargeted high-
coverage metabolomic approach we have measured the small molecule content of
these vesicles in contrasting in vitro conditions to establish what role these metabolites
could perform when packed into these vesicles. B. thetaiotaomicron packs OMVs
with a highly conserved core set of small molecules which are strikingly enriched with
mouse-digestible metabolites and with metabolites previously shown to be associated
with colonization of the murine GIT. By use of an expanded genome-scale metabolic
model of B. thetaiotaomicron and a potential host (the mouse) we have established
many possible metabolic pathways between the two organisms that were previously
unknown, and have found several putative novel metabolic functions for mouse that are
supported by gene annotations, but that do not currently appear in existing mouse
metabolic networks. The lipidome of these OMVs bears no relation to the mouse
lipidome, so the purpose of this particular composition of lipids remains unclear. We
conclude from this analysis that through intimate symbiotic evolution OMVs produced
by B. thetaiotaomicron are likely to have been adopted as a conduit for small molecules
bound for the mammalian host in vivo.
Keywords: Bacteroides thetaiotaomicron VPI-5482, outer membrane vesicle, metabolomics, genome-scale
metabolic modeling, host–microbe interaction
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INTRODUCTION
The mammalian gastrointestinal tract (GIT) harbors a vast
number and diversity of microbes which through extensive
co-evolution have come to play a vital role in mammalian
growth and health, particularly in both the development
and maintenance of the immune system and in mammalian
metabolism, previously reviewed extensively (Round and
Mazmanian, 2009; Clemente et al., 2012). The intestinal
microbiota degrades host-indigestible materials such as
plant polysaccharides, maintains the structural integrity
of the intestinal mucosal barrier, and protects against
pathogen invasion. Fundamental to maintaining host–microbe
relationships and a healthy GIT is effective cross-kingdom
communication. As direct contact between luminal microbes
and host cells in the GIT is highly restricted and normally
prevented by a sterile mucus layer coating boundary epithelial
cells (Johansson et al., 2008) effective communication between
members of the microbiota and host cells relies on diffusible
soluble mediators that can be delivered as free secreted products
or contained within microvesicles such as outer membrane
vesicles (OMVs) produced predominantly by Gram-negative
bacteria (Stentz et al., 2014). A review of the functions and
biogenesis of OMVs from Gram-negative bacteria was published
recently (Schwechheimer and Kuehn, 2015).
One of the most abundant phyla present in the intestinal
microbiota of both mouse and human is Bacteroides of
which B. thetaiotaomicron VPI-5482 (Bt) is a prominent
member and is used as a model in studies of host–bacterium
interactions (Eckburg et al., 2005). Bt contributes to carbohydrate
fermentation and the production of a pool of volatile fatty acids
that are reabsorbed through the large intestine and utilized by
the host as an energy source, providing a significant proportion
of the host’s daily energy requirement (Hooper et al., 2002).
Characteristically of Bacteroides, Bt contains a large complement
of glycosylhydrolases enabling it to cleave a great number of the
glycosidic bonds found in nature (Xu et al., 2004) which would
undoubtedly give it a competitive advantage in its intestinal
habitat.
Bacteroides thetaiotaomicron VPI-5482 produces OMVs that
have been implicated to play a role in host metabolism (Rakoff-
Nahoum et al., 2014), intracellular signaling (Stentz et al., 2014),
and antimicrobial resistance (Stentz et al., 2015) as well as
commensal microbial ecology and innate immunity (Hooper
et al., 2003; Zakharzhevskaya et al., 2017). Bt-produced OMVs
can promote colitis via the acquisition by and activation of
host immune cells (Hickey et al., 2015), though the closely
related B. fragilis can ameliorate host pathology by inducing
enhanced regulatory T-cells and anti-inflammatory cytokine
production (Shen et al., 2012). The internalization of E. coli
OMVs by cultured polarized colonic epithelial cells shows that
OMVs are internalized by host cells (José Fábrega et al., 2016),
suggesting that metabolites present in OMVs could in principle
be utilized for host metabolism. In addition to protein and
polysaccharide delivery OMVs have been shown to mediate
metabolic transfer in the form of inter-species carbon flux
(Biller et al., 2014). While 13C-labeled fluxomics combined
with metabolomics has been used to show metabolic activity
within OMVs produced by enteropathogenic Bacteroides fragilis
(Zakharzhevskaya et al., 2017), to date the role of OMVs in
metabolic exchange between intestinal bacteria and their hosts
has not been investigated.
Constraint-based genome-scale metabolic models (GEMs)
have been used extensively in the analysis of bacterial and
mammalian metabolism. The complete set of reactions known
to be catalyzed in a particular organism can be formulated as
a set of linear equations, a GEM, enabling the use of linear
optimization techniques (including flux balance analysis, FBA) to
tackle such problems as drug target identification (Raman et al.,
2005), strain optimization for bioethanol production (Sengupta
et al., 2013), and the elucidation of metabolic interactions during
host infection by bacteria (Bordbar et al., 2010). FBA has
been applied to multiple reconstructed metabolic networks of
bacteria to show metabolic interactions between these bacteria
when co-existing in a bacterial community in the human gut
(Shoaie et al., 2013). Also an integrated model of the germ-
free mouse and Bt metabolism has been created which captures
the mutualistic nature of their metabolic interactions (Heinken
et al., 2013). Heinken et al. (2013) showed the extent of the
metabolic dependency between the two organisms, along with
predictions for rescue of mouse growth phenotypes due to Bt
metabolic activity. Recently metabolic reconstruction of over
750 gut-residing bacteria has been undertaken, paving the way
for large-scale computational studies of metabolic interactions
between the entire microbiota and the host (Magnúsdóttir
et al., 2017). Additional applications of GEMs to the gut
microbiota have recently been reviewed in detail (van der
Ark et al., 2017). However, despite recent leaps in the ability
to reconstruct and analyze such networks, even those of
the most well-studied organisms are incomplete and limited
by our biochemical knowledge. Unresolved impediments to
the completion of such networks include uncharacterized,
misannotated, or incompletely annotated enzymes, and when
models are combined to study metabolic interactions the
mechanisms of such interactions are not always clear.
In the present study, the small molecule content of OMVs
produced by B. thetaiotaomicron in vitro has been investigated
using a high coverage untargeted metabolomics analysis and in
silico constraint-based modeling. A core set of metabolites has
been identified that is packed into OMVs in two contrasting
conditions. We have adapted and expanded an existing host–
microbe constraint-based metabolic model to allow for the
possibility of cross-kingdom metabolite transport via OMVs. By
combining experimental data with FastGapFill (FGF) (Thiele
et al., 2014), an algorithm for inferring missing reactions in
incomplete metabolic networks, we have linked the observed
metabolites in OMVs to both the Bt and mouse metabolic
networks. By computational interrogation of this expanded
model (using FBA) we have shown that the core set of
available OMV metabolites is significantly enriched in in silico
mouse-consumable metabolites. This metabolomic study and
consequent in silico analysis offers compelling evidence that
OMVs offer a potential conduit for metabolic interactions
between gut bacteria and their mammalian hosts.
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FIGURE 1 | Summary of metabolomics results. Venn diagrams of
metabolomic results for B. thetaiotaomicron and its OMVs grown in vitro in
rich and defined media. Subfigures (A) and (B) show overlap of all identified
metabolites in each of the compartments considered in RM and DM,
respectively. Subfigures (C) and (D) show cell and OMV contents that could
be mapped to KEGG metabolites along with those metabolites inferred to be
exported directly to the medium between TP1 and TP2, in RM and DM,
respectively.
RESULTS AND DISCUSSION
OMVs Contain a Core Set of Metabolites
Bt was cultured in rich medium (RM) and defined medium
(DM), and samples were taken to assess its metabolite
complement during exponential growth and shortly after entry
into stationary phase (time points 1 and 2, respectively – TP1
and TP2) with the cellular, extracellular, and OMV contents
under these different conditions analyzed by reverse phase
(RP)/Ultrahigh Performance Liquid Chromatography-Tandem
Mass Spectroscopy (UPLC-MS/MS) (ESI+) (−ESI) (Evans et al.,
2014). OMV sizes were measured by nanoparticle analysis to be
between approximately 40 and 700 nm in diameter. To assess
the consistency of metabolite presence calls in each sample,
the fraction of metabolites detected in all three replicates or
no replicates in each sample was calculated. Over 93% of all
measured metabolites in all samples were consistently present or
absent in all replicates, indicating high consistency in measured
replicates. In all 507 metabolites were identified by Metabolon in
at least one of the conditions. Details of these metabolites can
be found in Supplementary Table 1, which also contains details
of what data are missing for each metabolite. Figure 1 shows a
summary of the observations of the metabolites during stationary
phase in both RM (Figure 1A) and DM (Figure 1B); there is a
lot of overlap in the contents of the three compartments in both
media though there is an appreciable number of metabolites only
seen in OMVs.
Table 1 shows the number of metabolites in each super-
pathway in each cellular and OMV sample analyzed. Strikingly
similar numbers can be seen for the two time points in each
medium, indeed of the 297 metabolites observed in DM at TP1
or TP2 over 90% are present at both time points (the figure
is 84% in RM). This consistency is despite presumed depletion
of the medium during growth and the switch to the stationary
phase metabolic mode. The distribution of metabolites is similar
between cell and OMV (in both media), apart from a large
enrichment in lipids in OMVs with respect to cells. While 16%
(15%) of the cellular metabolites are lipids in RM (DM), 28%
(35%) of OMV metabolites are lipids. Although OMV lipids must
somehow allow for the diversity of curvature required for the
different sizes of OMVs observed in vitro and for very much
higher surface-area-to-volume ratios than normal cells, there
is no indication from this work why the repertoire of lipids
should be so much greater than that of their originating cells.
The difference between OMV content in rich (RM OMV) and
defined (DM OMV) media was assessed. While many metabolites
are seen solely in RM OMVs (181) a further 154 metabolites
are observed in both, and only four metabolites seen solely in
DM OMVs. This pattern of metabolite presence extends to the
cell, only 10 of the 281 metabolites observed in cells grown in
DM are absent in cells grown in RM. These results support the
idea that rather than running differing modes of metabolism
in both media, there is instead a core metabolism that runs
in the cell producing consistent “core” metabolite pools and
OMV contents. Given that the environment experienced by
Bt in vivo is variable, but that the chyme entering the lower
GIT is poor in nutrients (Spiller, 1994), the DM environment
would appear to mimic more closely these in vivo conditions.
The additional metabolites seen in the cell and RM OMVs are
therefore supplementary to this core metabolism and could be
by-products of the metabolic processes active in the cell during
growth in this replete medium.
An updated and extended metabolic model, denoted
iMM_BT_OMV, was created to take into account the
metabolomic data presented here. The number of compartments
was increased by 3 to allow separate mouse and Bt
cytosol/extracellular space, and the addition of OMVs as
a potential metabolite transfer route. Two hundred and
nineteen KEGG-mapped metabolites were added to the OMV
compartment, requiring the addition of 438 “transport” reactions
to represent the packing of the metabolites into OMVs by Bt and
their potential uptake by mouse. Gap filling provided another
212 putative reactions in the Bt cell and 269 in the mouse
cytosol amounting to 15% and 7% increases in the total number
of reactions in each organism. Validation was undertaken by
a manual search for catalyzing enzymes for those reactions
in mouse that had substrates in the pool of available OMV
metabolites.
Each metabolite in the Bt cell in the model was tested for
essentiality for in silico growth in the DM using this model.
This was done by preventing flux in all reactions involving each
metabolite in turn, and running FBA to test whether growth
was maintained when the metabolite was neither produced nor
consumed. The in silico “essential” metabolites were therefore
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TABLE 1 | A summary of the types of metabolites found by untargeted metabolomics in each cellular and OMV sample.
Super pathway Defined medium Rich medium
Cells OMV (DM OMV) Cells OMV (RM OMV)
6 h (TP1) 12 h (TP2) 2.5 h (TP1) 5 h (TP2)
Amino acid 79 76 36 99 116 89
Carbohydrate 38 37 16 40 39 32
Cofactors and vitamins 29 29 5 30 30 15
Energy 8 8 6 8 9 8
Lipid 42 42 55 69 59 95
Nucleotide 53 51 20 64 65 42
Peptide 23 24 15 26 27 29
Xenobiotics 16 14 5 19 21 25
Total 288 281 158 355 366 335
Each number represents the count of metabolites in each super pathway (based on KEGG super pathways). Cell samples are classified by time of sample (in hours) and
all samples have their abbreviation in the text in brackets.
those which had to be either produced or consumed (or
both) in silico to be consistent with experimental observations.
This essentiality is not a prediction of presence in measurable
amounts in the cell, as metabolic turnover in cells is very high
and production and consumption can be finely balanced to
eliminate the accumulation of unwanted (for instance toxic)
small molecules.
Cell contents at TP2 are correlated with OMV contents in
the RM (p = 0.015), but there is a much more pronounced
relationship in DM (p = 5.9 × 10−14). There is not a correlation
between the non-essential metabolites in RM cells and OMVs
at TP2 (p = 0.054); however, in DM the correlation remains
significant (p = 6.6 × 10−11). This appears counter-intuitive,
as it might be expected that cells under nutrient stress would
avoid accumulation of metabolites that were not necessary for
survival of the cell. In this case the cells would drop pools of
metabolites whose only (apparent) function is as contents of
produced OMVs. In DM cell contents are correlated with in
silico essential metabolites but there are still 78 observed small
molecules which are not essential in silico, nor are they seen in
DM OMVs. Forty-five of these are observed in RM OMVs, so a
potential reason for their presence is in readiness for a change in
nutrient availability at which point they can be released to OMVs.
Metabolites seen in OMVs in both media (“core” OMV
metabolites) are significantly more likely to have been observed
in Bt cells in RM (p= 4.6× 10−4) than metabolites only observed
in RM OMVs. Cells grown in RM maintain measurable pools
of 112 metabolites that are also observed in OMVs produced by
those cells. Sixty-four of these pools are depleted in cells grown
in DM, but of those metabolites seven are maintained in OMVs
produced in DM. Not only does this imply an important role for
these seven metabolites, but also it indicates the control that Bt
has over the small molecule content of released OMVs. For these
metabolites at the very least, their presence in the OMV is not a
by-product of their presence in the cell, but of specific packing
into OMVs despite a lack of a measurable pool of metabolites
from which to draw. Three of these metabolites have a role in
osmoregulation and are therefore implicated in the stability of
OMVs (Burg and Ferraris, 2008): arabitol, betaine, and genistein.
Further, pilot NMR studies (unpublished data) have suggested
that in RM betaine, mannitol and trehalose are among the most
abundant OMV contents, though only betaine is seen in DM. The
high stability of OMVs (Arigita et al., 2004; Kulp and Kuehn,
2010) could be at least partly explained by the presence of these
molecules in their luminal space, along with other osmolytes
observed such as carnitine, proline, and choline. Bt also limits
the packing of some metabolites into OMVs, even when they are
observed in the cells. There are 69 metabolites that are present
in RM OMVs that are not exported to OMVs when cells are
grown in DM, despite the cell maintaining measurable pools of
those metabolites in the DM. The control exerted by Bt over its
OMV small molecule contents, going as far as blocking available
metabolites and packing metabolites with limited availability in
the cell into OMVs must be for some biological purpose as it
represents a significant investment of energy (Roier et al., 2016).
Bt Preferentially Packs OMVs with
Molecules Metabolized in Silico in the
Mouse
To test the assertion that the core metabolites packed into
OMVs are intended for the mammalian host, the predicted
consumability of those metabolites by mouse (in silico according
to iMM_BT_OMV) was calculated using FBA. For a metabolite
to be useful to the host, the host must have an enzyme (or set
of enzymes) to catalyze the conversion of that metabolite to a
useful product. In order to enable unambiguous testing of in
silico consumability of metabolites, only those metabolites which
could be mapped to the KEGG database (Kanehisa et al., 2012),
and therefore to KEGG reactions which were amenable to FBA
analysis, were considered. To link the extracellular metabolomics
data to internal Bt metabolism, metabolite export was calculated
by observation of metabolite concentration changes between TP1
and TP2 in each extracellular sample. Figures 1C,D summarize
the KEGG-mapped metabolites and their export from the
bacterium in RM and DM, respectively.
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For the in silico consumability analysis the integrated model
was subjected to the availability of metabolites based on the
Western Diet as defined by Heinken et al. (2013) and enrichment
was calculated with respect to the proportion of consumable
KEGG-mapped metabolites in the entire metabolomics dataset.
In this environment there is a significant enrichment of
consumable metabolites in the OMV (p = 0.008), whereas
mouse-consumable metabolites are not significantly over-
represented in the set of directly exported small molecules
(p = 0.33). A lack of information on which metabolites are
measurable in this analysis makes further statistical analysis
difficult. It is, however, worth noting that while 62% of the
metabolites producible by Bt (in silico) with nutrient availability
as set above are consumable by mouse, 93.5% of the KEGG-
mapped core OMV metabolites are consumable. These results
are a clear indication that Bt preferentially packs its OMVs with
metabolites that the mouse can metabolize.
To identify whether a particular pathway or set of pathways
is targeted by Bt with its OMV contents, the distribution of
core OMV metabolites in KEGG pathways was investigated by
metabolite set enrichment analysis (Xia et al., 2015). The results
show that OMV contents are not significantly enriched in any
KEGG metabolic pathways (either in mouse or Bt) with respect to
the metabolites imported to Bt, observed in Bt cells, or predicted
essential in silico. It seems therefore that no particular pathways
are targeted by Bt, so any specific metabolic response expected
from the host or insufficiency in the host appears to be targeted
only by individual metabolites.
Although the selections of medium for this study do not
mimic conditions in the mammalian colon, they were selected for
the purposes of establishing a baseline OMV metabolite content
in defined minimal media. The RM was selected in order to
establish the potential range of metabolites exportable via OMVs
in replete conditions. In vivo the nutrient content of the colon
is poor, but variable. Actual OMV contents in vivo are highly
variable depending on available substrates and physiological
conditions, but we hypothesize that they will contain a large
fraction of the core metabolome, along with other condition-
specific metabolites. We have also established a large set of
metabolites that we now know can be packed into OMVs by
Bt. Establishing exact in vivo OMV complements will require
considerable further experimental work. We note, however, that
our analysis shows a clear enrichment of mouse-consumable
small molecules in the observed core metabolome indicating
that our choices of medium are sufficient to begin probing the
metabolic exchange between Bt and mouse via OMVs in vivo.
OMV Metabolites Are Associated with
Colonization of the Murine GIT
A previous study has identified a set of metabolites that
discriminate between germ-free and conventionally reared mice
(Claus et al., 2008), being absent in the former and present
in the latter. In that study these metabolites were found in
various tissues in the mouse including kidney, liver, and various
sections of the GIT. The core OMV metabolites identified
in this study is significantly enriched in these metabolites
FIGURE 2 | Summary of model expansion. The compartments of model
iMM_BT_OMV that are affected by the presence of OMVs in the model.
Numbers by solid arrows represent numbers metabolites that can cross
compartment boundaries. Green dashed arrows represent the overlap
between exported metabolites from one organism and imported metabolites
to the other organism, along with the sizes of these overlaps. All OMV
metabolites can potentially be transported from Bt to mouse. The cream
dashed arrow represents the transfer from Bt to mouse via OMVs, and
indicates the number of metabolites only transferrable via this route. The
system boundary indicates how the model is connected to the dietary intake
of nutrients and excretion from the GIT (via the lumen).
(p = 3e−68), containing 20 of the 25 metabolites that could
be mapped between this study and that of Claus et al. (2008).
A tantalizing interpretation of these observations is that Bt might
directly supply these metabolites in appreciable quantities to the
host via their OMVs. Further metabolomic experimentation on
gnotobiotic mice colonized by Bt would be required to confirm
this empirically. Metabolites that are directly exported by Bt are
also significantly enriched in these discriminating metabolites
(p= 5e−58), accounting for one additional metabolite of the 25.
All eight amino acids (classified as peptides) that were
significantly different between GF- and conventionally reared
mice in the study of Claus et al. (2008) are observed in OMVs
in this study, and none are present in the DM itself, suggesting
that Bt, one of the dominant members of the human intestine
microbiota (Eckburg et al., 2005), could play a role in amino
acid biosynthesis in vivo, using OMVs as the channel for their
transport to the host.
The Core OMV Metabolome Enables
Putative Functional Annotation of
Enzymes in Mouse
Figure 2 shows the compartments that are affected by the
addition of an OMV compartment to the expanded model
(enabling metabolite transfer from Bt to mouse) and the
numbers of metabolites that can be transferred between these
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compartments according to the metabolites observed in OMVs in
either medium. It shows that while 69 metabolites that are directly
exportable by Bt can be taken up by the mouse, OMVs enable the
transport of a further 77, increasing the repertoire of potential
metabolic interactions greatly. Gaps created by the addition of
the OMV compartment in the expanded model iMM_BT_OMV
were addressed using FGF (Thiele et al., 2014), which was run
during the creation of the expanded model to find candidate
reactions to link metabolites seen in the OMV with mouse
metabolism.
In all 87 of the 104 consumable core OMV metabolites in the
expanded model are in silico consumable in the original metabolic
model iexGFMM_B2. FGF found a suitable set of reactions to
add to the model to enable the connection of the remaining
17 to the mouse metabolic network. Two of these metabolites,
creatinine and L-homoserine, exist in the original model mouse
cytosol, but are not consumable in that model. The remainder do
not take part in any known reactions in the mouse and are only
convertible to a usable substrate by the addition of extra reactions.
Table 2 shows a list of the 17 metabolites for which reactions were
inferred to be present in mouse by FGF.
Figure 3 shows an example of reactions added due to
the presence of a metabolite in the OMV, in this case L-
methionine S-Oxide (LMSO). LMSO was observed in OMVs
in both media so is predicted to be transferred to mouse,
but there is no known existing reaction connecting LMSO to
the rest of mouse metabolism. FGF predicted the reaction L-
methionine:oxidized-thioredoxin S-oxidoreductase (KEGG ID:
R02025) and consequently by database search two genes were
found, the products of which together are predicted to constitute
an enzyme catalyzing this reaction. L-Methionine is an essential
amino acid and was shown by Heinken et al. (2013) to be
competitively taken up by mouse and Bt in silico. However, the
presence of S-oxidized L-methionine in OMVs produced in both
media indicates that Bt does not compete directly with the host
for L-methionine, produces it in measurable quantities inside the
cell in both conditions and even exports it via OMVs, presumably
with the intention of providing the host with this amino acid.
For all reactions added by FGF, reversibilities [initially
calculated using eQuilibrator (Noor et al., 2012)] were checked
against their curated KEGG reaction reversibilities. Several were
inconsistent and in these cases the curated reversibility was
adopted in the model. This resulted in two metabolites, alpha-
isopropylmalate and phytosphingosine, becoming inconsumable
in the mouse cytosol. In four cases FGF added two reactions
for a DM OMV metabolite to make it consumable and in each
case both reactions were irreversible, with one reaction producing
the metabolite and one consuming it. Therefore, of the 17 DM
OMVs metabolites that were made consumable in the FGF gap
filling step, 15 were rendered consumable by the addition of
just a single metabolic reaction per metabolite. For one of these,
erucic acid, unblocking was achieved in the model through a
transporter between the mouse cytosol and extracellular space
(toward the lumen) rather than through integration into mouse
metabolism. There is therefore no indication of how (and if)
this metabolite connects with mouse metabolism, so it was not
analyzed further.
The inference by gap filling of additional reactions to consume
14 extra metabolites in the updated model does not guarantee
that these reactions can actually occur in vivo in the mouse so
evidence for enzymes catalyzing these reactions was sought in
MouseCyc (Evsikov et al., 2009) and the NCBI Gene database
(NCBI Resource Coordinators, 2016). Five enzymes were found
fitting five of the enzymatic roles required and are listed in the
last column of Table 2. Lipe is annotated in the NCBI Gene
database as a hormone-sensitive lipase, and we propose that
it catalyses a monoacylglycerol acylhydrolase reaction. Acot2 is
associated with reactions MMPTE2x, MMPTE3x, MMPTE4x,
and MMPTE5x, a set of peroxisomal acyl CoA thioesterase
reactions in the original mouse metabolic model, which share
the EC number, 3.1.2.2, with the Linoleoyl-CoA hydrolase
function proposed in this model. Gpcpd1 is annotated as a
glycerophosphocholine phosphodiesterase in the Gene database,
we propose that specifically it has a glycerophosphohydrolase
function on glycerophosphoethanolamine.
Sord, associated in the model with the D-sorbitol
dehydrogenase reaction MMSBTD_D2, is proposed additionally
to have specificity for L-Iditol. The final proposed enzyme is
heteromeric, consisting of Msrb2 and Msrb3 subunits which
are annotated in the Gene database with a methionine sulfoxide
reductase enzymatic function. We propose that this function
is undertaken by this enzyme in the mouse (as illustrated in
Figure 3). It should be noted that due to the potential for
enzyme promiscuity these proposed functions are not intended
to supersede previous annotations but as additional putative
functions.
In addition, MouseCyc includes the O-acetyl-L-homoserine
acetate-lyase reaction (KEGG:R01287) in the metabolic network
of mouse, indicating that although it is not in the published
model of mouse metabolism it is known with some confidence
to be catalyzed in mouse, but that the relevant enzyme has not
been identified to date. Although literature searches failed to find
empirical evidence to support the functional inferences made
here, it is striking that putative enzymes could be found for more
than a third of the reactions predicted to be present.
OMV Lipids Are Not Enriched with Lipids
Found in Mouse Membranes
Twenty KEGG-identified lipids are contained in the lipid
membrane of OMVs produced in DM and 12 of these are
contained in the original mouse model (the mouse submodel
of iexGFMM_B2), but this does not represent an enrichment
of mouse lipids in OMVs with respect to all Bt lipids (the
mouse shares 36 out of the 78 lipids produced by Bt according
to iexGFMM_B2). Fourteen of the lipids observed at TP2 in
Bt cells grown in DM are contained in the OMV membrane,
but of the additional six produced by Bt specifically for OMVs
(i.e. not seen in cell samples) only one is present in the original
mouse model. OMV lipid content is therefore not driven by a
requirement for similarity to the host lipid membrane. Without
further experimental investigation, it is not possible to say which
subset of the observed lipid complement in Bt cells is part of the
outer membrane of Bt, but this addition of six further lipids to
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TABLE 2 | The proposed reactions by which metabolites present in the OMV could be connected to mouse metabolism.
BiGG ID Common name Reaction(s) Producibility/
consumability
Required enzyme
(EC number)
Enzyme in mouse
(Gene ID)
13zdst Erucic acid Exporter
(“13zdstt-_rev_e”)
P/C – –
1ag 1-Acylglycerol R07293 (R) P/C Monoacylglycerol acylhydrolase Lipe (16890.1)
3amp Adenosine
3′-phosphate
R01562 (I) NP/C 3′-AMP phosphohydrolase (3.1.3.6) –
R03537 (I) P/NC 2′,3′-Cyclic AMP 3′-nucleotidohydrolase
(3.1.4.16)
–
3c3hmp Alpha-Isopropylmalate R01213 (I) P/NC Acetyl-CoA:3-methyl-2-oxobutanoate
C-acetyltransferase (2.3.3.13)
–
9z12zocdcya Linoleate R08177 (I) NP/C Linoleoyl-CoA hydrolase (3.1.2.2) Acot2∗ (171210.1)
Achms O-Acetyl-homoserine R01287 (I) NP/C O-Acetyl-L-homoserine acetate-lyase
(2.5.1.49)
–
R01776 (I) P/NC Acetyl-CoA:L-homoserine
O-acetyltransferase (2.3.1.31)
–
Crtn Creatinine R01884 (R) P/C Creatinine amidohydrolase (3.5.2.10) –
g3pe Glycerophospho-
ethanolamine
R01470 (I) NP/C Glycerophosphohydrolase (3.1.4.2) Gpcpd1 (74182.1)
Genistein Genistein R06553 (I†) NP/C Isoflavone synthase –
hom__L L-Homoserine R01776 (I) NP/C Acetyl-CoA:L-homoserine
O-acetyltransferase (2.3.1.31)
–
R00175 (I†) P/NC S-Adenosyl-L-methionine hydrolase
(3.3.1.2)
–
idt__L L-Iditol R07145 (R) P/C L-Iditol:NAD+ 2-oxidoreductase Sord∗ (20322.1)
Malon Malonate R00743 (R) P/C Acetyl-CoA:malonate CoA-transferase
(2.8.3.3)
–
Maltttr Maltotetraose R03801 (I) NP/C 1,4-Beta-D-Glucan glucohydrolase
(3.2.1.74)
–
R03802 (I) P/NC 1,4-Beta-D-Glucan glucohydrolase
(3.2.1.74)
–
metsox_S__L L-Methionine S-oxide R02025 (I) NP/C L-Methionine:oxidized-thioredoxin
S-oxidoreductase
Msrb2 and Msrb3
(76467.1 and
320183.1)
psphings Phytosphingosine R06525 (I) P/NC Sphinganine, ferrocytochrome b5:oxygen
oxidoreductase
Degs2 (70059.1)
rbn__D D-Ribonate R01079 (R†) P/C D-Ribose:NADP+ 1-oxidoreductase
(1.1.1.115)
–
saccrp__L Saccharopine R00715 (R) P/C N6-(L-1,3-dicarboxypropyl)-L-lysine:NAD+
oxidoreductase (1.5.1.7)
–
Reactions are referenced by KEGG ID and proposed mouse genes include NCBI gene ID. Further abbreviations are as follows for properties of the reactions in mouse:
R, reversible; I, irreversible; P, producible; NP, not producible; C, consumable; NC, not consumable. ∗Enzymes already present in the original model, but annotated with
other roles; †data from ModelSEED (Henry et al., 2010).
OMVs where they are not present in the cell indicates that Bt
controls the lipid complement of OMVs for some purpose.
These extra lipids are not significantly shorter than those
in Bt cells, nor are they significantly more saturated than the
lipids present in those cells, so they do not appear to be added
to accommodate the extra curvature of OMVs due to their
physical or chemical properties. Other possible mechanisms
driving membrane curvature and OMV biogenesis have been
reviewed previously (Schwechheimer and Kuehn, 2015). There is
evidence that internalization of E. coli OMV contents in Caco-2
cells can be achieved via membrane fusion (José Fábrega et al.,
2016), but the fate of the non-mouse lipid content of the OMVs
on fusion with host cells remains unknown. Every lipid found in
OMVs from DM is also present in OMVs from RM, reflecting
the additive nature of OMV packing by Bt when provided with
additional nutrients. Other possible reasons for the observed
lipids in OMVs could be as artifacts of sample preparation and
storage, or as degradation products of active enzymes within
the vesicles. Investigation of this second possibility will require
proteomic analysis to identify lipid-degrading enzymes in these
vesicles.
One hundred and twenty of the 339 metabolites observed
in OMVs could not be mapped to KEGG IDs including 46
core OMV metabolites, so their metabolic impact could not
be analyzed through FBA; however, there is information from
Metabolon about their classification in (KEGG-based) super
pathways. These 46 include 26 lipids and 14 dipeptides. Including
these data with the KEGG-mapped core metabolite data, lipids
Frontiers in Microbiology | www.frontiersin.org 7 December 2017 | Volume 8 | Article 2440
fmicb-08-02440 December 8, 2017 Time: 12:9 # 8
Bryant et al. Bt OMV Metabolomics and Modeling
FIGURE 3 | L-Methionine S-oxide (LMSO) transport and utilization pathway. The addition of reactions to model iMM_BT_OMV to represent transfer of LMSO by
OMV from Bt to mouse and the enzyme found that could reduce LMSO to L-methionine in mouse. Squares represent reactions and circles represent metabolites,
separated into their relevant compartments, “c,” “o,” and “cm,” in the model. Arrows show the direction of reaction flux; solid lines represent parts present in the
original model, dash-single-dot lines represent parts added in OMV metabolism and dash-double-dot lines represent the reaction added during gap filling to link
imported LMSO to mouse metabolism (by reduction). Reaction names and summaries are underlined.
make up 21 of the 29 core metabolites that are not found in
Bt cells during growth on DM. The absence from the KEGG
database of such a high proportion of lipids indicates that lipids
are under-represented in this reaction database. Conversely, all
15 of the dipeptides in the core metabolite set are seen in Bt cells
as well, but it is currently unclear what significance this has for
the function of the dipeptides.
Challenges in Elucidating Host–Microbe
Metabolic Interactions via OMVs
Most digestion initiates in the small intestine before the chyme
is transferred to the colon, the segment of the GIT in which Bt
mostly resides. Dietary differences between individuals and the
pre-distal digestion would both have a large impact on nutrient
availability in the colon and consequently an impact on the details
of the consumability and producibility of metabolites by Bt.
Although DM has been used to grow Bt for this analysis, it is not
fully representative of the conditions and nutrient supply in the
GIT. More precise specification of the availability of nutrients to
Bt in vivo requires further experimentation, which would help to
characterize better the OMV-mediated metabolic transfers from
Bt to mouse.
In this study we have presented good evidence that Bt packs
OMVs with metabolites that are targeted at the mammalian host,
but several large questions remain unanswered from this analysis.
Due to the lack of absolute quantification of OMV contents it is
difficult to estimate the size of the impact that these metabolites
might have on host cell metabolism. Many contents of the OMVs
have been observed by Claus et al. (2008) in a mouse host only
when bacteria are present in its GIT, but this is not sufficient to
deduce their source to be OMVs produced by these bacteria. On
the other hand, OMVs are known to be continuously produced
by Gram-negative bacteria. OMV numbers were measured by
nanoparticle tracking analysis, and found to be at similar levels
[3 × 1011 (RM) and 5 × 1011 (DM) particles when adjusted to
the total number]. Therefore, lack of nutrient availability does not
appear to restrict OMV production, and the potential of OMVs
to be metabolic mediators.
The inability to quantify the metabolites also means that it
is impossible to determine which, if any, of the metabolites
dominate the OMV, and which are only present in trace amounts.
It therefore remains an open question to what extent and in what
way mammalian metabolism is impacted by the small molecule
content of OMVs. Discussion of specific metabolites here is
therefore limited to their general classification and consumability
in the mouse, and further investigation will be required to
establish the exact role that OMVs take in mediating metabolism
between host and bacterium. Analysis of OMVs from other
prominent bacterial species in the human GIT would offer further
insights into this conventionally overlooked route for metabolite
exchange in the human gut.
Applications to Modeling
Human–Microbe Co-metabolism
Several attempts have been made to date to capture co-
metabolism of host and microbe in the GIT in a systematic and
representative way, in a model that is amenable to computational
analysis (Heinken et al., 2013; Shoaie et al., 2013; Shoaie and
Nielsen, 2014; Magnúsdóttir et al., 2017). An extension of
these models to a human–microbe system has been undertaken
wherein the idea of co-metabolism, viewing the GIT as just
another organ in a model of human metabolism, is formalized in
a constraint-based metabolic model (Heinken and Thiele, 2015).
We have found that adding OMVs to such models would allow
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for a more comprehensive representation of the link between the
GIT microbial “organ” and the rest of the human body.
Conclusion
An investigation of the metabolomic content of Bt and the
OMVs it produces, combined with FBA of an integrated
mouse-Bt metabolic model, has shown that Bt controls the
metabolite complement of OMVs and that the resulting
metabolite profile is enriched for metabolites that its murine
host can metabolize. Furthermore, these OMVs are greatly
enriched in metabolites implicated in the distinctive metabolic
profiles of conventionally reared mice as opposed to germ-
free mice, whereas many of these metabolites are not excreted
directly by Bt. These data illustrate the potentially crucial
role OMVs play in metabolic interactions between bacterium
and host over and above their established roles in immune
modulation and in the breakdown of host-indigestible glycans.
While this represents a step toward a greater understanding
of these interactions, a lack of in vivo data means that
conclusions about the specific effects of OMVs on host
metabolism cannot yet be made. We do, however, present
several mouse enzyme function predictions which if borne
out would show that exogenous metabolite uptake from Bt
(and presumably many other bacterial species present in
the GIT) plays a significant role in host (mouse) metabolic
evolution. The expanded metabolic model presented here should
enable more realistic simulations of the mouse-Bt metabolic
system taking these additional points of metabolic contact
into account. The lipid content of OMVs appears not to
be enriched for lipids present either in the murine large
intestine or in mouse tissues in general (as inferred in silico),
leaving the difference between the Bt lipid content and that
of its OMVs unexplained. Also, as with many metabolomics
experiments to date, these data throw a spotlight on the
incompleteness of both metabolite and reaction databases and
also of even recently curated metabolic models; the number
of lipids unidentified in these databases shows that this is
particularly the case in lipid metabolism. Together these analyses
offer new and potentially important insights into a crucial
aspect of host–microbe interactions that had thus far remained
unexamined.
MATERIALS AND METHODS
Sample Preparation
Bacterial Cell and Medium Extracts
The bacterium Bacteroides thetaiotaomicron VPI-5482 was
grown anaerobically at 37◦C with agitation using a magnetic
stirrer in either Brain Heart Infusion medium (Oxoid/Thermo
Fisher, Basingstoke, United Kingdom) with 0.001% hemin (rich
medium, “RM” or in Bacteroides DM (“DM,” see Table 3) adapted
from Martens et al. (2008).
For each medium 3 culture flasks were grown independently
for each time point. Cells from overnight cultures were rinsed
once with phosphate-buffered saline (PBS) and used to inoculate
200 ml fresh medium in 500 ml flasks at an OD of 0.05.
TABLE 3 | The concentrations of all small molecules present in the Bacteroides
Defined Medium (DM) used to grow Bacteroides thetaiotaomicron.
Compound Concentration (pH 7.4)
KH2PO4 100 mM
NaCl 15 mM
(NH4)2SO4 8.5 mM
MgCl2 0.1 mM
L-Cysteine 4.1 mM
Vitamin B12 3.7 × 10−7 mM
Hematin 0.0015 mM
Glucose 0.5% w/v
CaCl2 50 µM
Histidine 0.2 mM
After 2.5 h in RM and 6 h in DM (OD approximately 0.5,
mid-exponential phase), 5 h in RM and 12 h in DM (OD
approximately 3.0, early stationary phase), the cell culture
(60 ml for mid-exponential phase and 10 ml for early stationary
phase) was collected using 5 ml syringes fitted with a 13 mm
diameter syringe filter with a 0.22-µm pore size hydrophilic
PTFE membrane (IC Millex R© – LG, Millipore) and filled with
pre-cooled 10–15 stainless steel spheres (5 mm diameter) at
−20◦C for rapidly cooling the broth for subsequent analysis
of extracellular material (Mashego et al., 2006). Two hundred
microliters of samples was collected in all cases. Sterile handling
of the samples was confirmed by plating of one of the six
samples in BHI–hemin agar. The cell culture was immersed
directly into liquid N2, followed by thawing in ice to keep the
cell suspension at 0◦C. The suspension was later centrifuged to
separate biomass from the supernatant at 5000 × g, 15 min,
4◦C, and rinsed once in the same volume of ice-cold PBS.
After removing the supernatant, the cell pellets were snap
frozen in liquid nitrogen and stored at −80◦C before extraction.
The dry weight measurement was performed on cell pellets
obtained from 30 ml cultures previously washed with one
volume of PBS. Although OMVs would have remained in the
supernatant, their concentration is small enough that their
contribution in these conditions to metabolomics signal is
negligible.
Bacterial OMV Extracts
In order to obtain a sufficient quantity of OMVs to detect
a metabolomic signal, 2 l of RM (three culture flasks
grown independently) and DM (three culture flasks grown
independently) were inoculated with overnight culture of
B. thetaiotaomicron at an initial OD of 0.0005 and 0.05,
respectively. The OMV extraction was performed as previously
described (Stentz et al., 2014) with slight modifications. After 16 h
(OD approximately 4.0), the cell cultures were rapidly cooled in
a manually shaken ice bath. The cultures were then centrifuged
at 5000 × g for 15 min at 4◦C, and the supernatants filtered
through a 0.22-µm Steritop filtration unit (Millipore, Billerica,
MA, United States) to remove debris and cells. The sterility of
the filtrate containing the vesicles was confirmed by plating onto
BHI–hemin agar. OMVs in the 2 l filtrates were concentrated
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by molecular weight (100 kDa MWCO, Vivaflow 200, Sartorius)
down to 2 ml, diluted by addition of 1 l of ice-cold PBS, pH 7.4,
and the suspensions were filtered and concentrated again, down
to 9 ml. The 9 ml retentate was ultracentrifuged [150,000 × g
for 2 h at 4◦C in a Ti70 rotor (Beckman Instruments)]. The
supernatant was completely removed using a vacuum pump and
a needle and the OMV pellets were snap frozen in liquid nitrogen
and stored at−80◦C before extraction.
Nanoparticle Analysis
Videos were generated using a Nanosight nanoparticle
instrument to count OMV numbers in each OMV sample.
The population of OMVs (moving due to Brownian motion) in
the sample was recorded and their motion was measured. Within
a specially designed and constructed laser illumination device
mounted under a microscope objective, OMVs in the sample
passing through a laser beam path were recorded as small rapidly
moving points of light (for sub-wavelength sized particles these
are simply scattering centers). The motions of these OMVs were
tracked to determine their velocity and numbers. Simultaneous
measurement of the mean squared displacement of each OMV
tracked, the particle diffusion coefficient (Dt), and hence sphere
equivalent hydrodynamic radius (rh) were determined using the
Stokes–Einstein equation,
Dt = kBT6piηrh
,
where kB is the Boltzmann’s constant, T is the temperature, and
η is the solvent viscosity.
Metabolomics
Samples were subject to metabolite extractions and analysis
by RP/UPLC-MS/MS (ESI+) (−ESI), and subsequent
bioinformatics data processing (Metabolon Inc., Durham,
NC, United States). Details of the methods used have been
published (Evans et al., 2014), and an outline of the process is
provided here.
Sample Preparation
Samples were prepared using the automated MicroLab STAR R©
system from Hamilton Company. DL-2-fluorophenylglycine,
tridecanoic acid, d6-cholesterol, and 4-chlorophenylalanine
were utilized as recovery standards. To remove protein,
dissociate small molecules bound to protein or trapped in
the precipitated protein matrix, and to recover chemically
diverse metabolites, proteins were precipitated with methanol
under vigorous shaking for 2 min (Glen Mills GenoGrinder
2000) followed by centrifugation. The resulting extract was
divided into five fractions: two for analysis by two separate
RP/UPLC-MS/MS methods with positive ion mode electrospray
ionization (ESI), one for analysis by RP/UPLC-MS/MS with
negative ion mode ESI, one for analysis by HILIC/UPLC-
MS/MS with negative ion mode ESI, and one sample was
reserved for backup. Samples were placed briefly on a TurboVap R©
(Zymark) to remove the organic solvent. The sample extracts
were stored overnight under nitrogen before preparation for
analysis.
Ultrahigh Performance Liquid
Chromatography-Tandem Mass Spectroscopy
(UPLC-MS/MS)
All methods utilized a Waters ACQUITY ultra-performance
liquid chromatography (UPLC) and a Thermo Scientific
Q-Exactive high resolution/accurate mass spectrometer
interfaced with a heated electrospray ionization (HESI-II)
source and Orbitrap mass analyzer operated at 35,000 mass
resolution. The sample extract was dried then reconstituted
in solvents compatible to each of the four methods. Each
reconstitution solvent contained a series of standards at fixed
concentrations to ensure injection and chromatographic
consistency. One aliquot was analyzed using acidic positive
ion conditions, chromatographically optimized for more
hydrophilic compounds. In this method, the extract was
gradient eluted from a C18 column (Waters UPLC BEH C18-
2.1 × 100 mm, 1.7 µm) using water and methanol, containing
0.05% perfluoropentanoic acid (PFPA) and 0.1% formic acid
(FA). Another aliquot was also analyzed using acidic positive
ion conditions; however, it was chromatographically optimized
for more hydrophobic compounds. In this method, the extract
was gradient eluted from the C18 column using methanol,
acetonitrile, water, 0.05% PFPA, and 0.01% FA and was
operated at an overall higher organic content. Another aliquot
was analyzed using basic negative ion optimized conditions
using a separate dedicated C18 column. The basic extracts
were gradient eluted from the column using methanol and
water, however, with 6.5 mM Ammonium Bicarbonate at pH
8. The fourth aliquot was analyzed via negative ionization
following elution from a HILIC column (Waters UPLC BEH
Amide 2.1 × 150 mm, 1.7 µm) using a gradient consisting
of water and acetonitrile with 10 mM ammonium formate,
pH 10.8. The MS analysis alternated between MS and data-
dependent MSn scans using dynamic exclusion. The scan
range varied slighted between methods but covered 70–
1000 m/z. Raw data files are archived and extracted as described
below.
Bioinformatics
The informatics system consisted of four major components,
the Laboratory Information Management System (LIMS), the
data extraction and peak-identification software, data processing
tools for QC and compound identification, and a collection of
information interpretation and visualization tools.
Raw data were extracted, peak-identified, and QC processed
using Metabolon’s in-house web-service platform. Compounds
were identified by comparison to library entries of purified
standards or recurrent unknown entities. Metabolon maintains
a library based on authenticated standards that contains
the retention time/index (RI), mass to charge ratio (m/z),
and chromatographic data (including MS/MS spectral
data) on all molecules present in the library. Biochemical
identifications were based on three criteria: retention index
within a narrow RI window of the proposed identification,
accurate mass match to the library ±10 ppm, and the MS/MS
forward and reverse scores between the experimental data
and authentic standards. The MS/MS scores were based
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on a comparison of the ions present in the experimental
spectrum to the ions present in the library spectrum. While
there may be similarities between these molecules based
on one of these factors, the use of all three data points
was used to enable differentiation of such biochemicals.
More than 3300 commercially available purified standard
compounds have been acquired and registered into LIMS for
analysis on all platforms for determination of their analytical
characteristics.
A variety of curation procedures were carried out to ensure
that a high-quality data set was made available for statistical
analysis and data interpretation. The QC and curation processes
were designed to ensure accurate and consistent identification of
true chemical entities, and to remove those representing system
artifacts, mis-assignments, and background noise. Proprietary
Metabolon visualization and interpretation software were used to
confirm the consistency of peak identification among the various
samples. Library matches for each compound were checked for
each sample and corrected if necessary. Data normalization was
performed according to the protein concentrations measured
with the Bradford assay (cells, extracellular milieu, and
vesicles).
Due to the nature of the above methods, metabolite
concentrations in similar conditions (e.g., different time points
in the same medium) are comparable. This enabled relative
concentrations to be calculated between such samples.
Data Analysis
Metabolomics Analysis and Interpretation
Metabolites were inferred to be present for a particular time
point (TP1 or TP2), OMV sample, or medium (DM or RM)
if they were measured in at least two of the three relevant
replicates. Metabolite presence in each sample is detailed in
Supplementary Table 1. FBA as detailed below was performed
using only those metabolites that could be mapped to a KEGG
ID, to ensure compatibility with pathway modeling. Where a
KEGG ID had not been assigned by Metabolon to an entry in
the list of metabolites, a KEGG ID was sought manually by
reference to ChEBI (Hastings et al., 2013) and Pubchem (Kim
et al., 2016), with any metabolites not identifiable by KEGG ID
excluded from the analysis. Significant changes in metabolite
concentrations in the media with respect to initial metabolite
concentrations (from pre-inoculation blanks) were inferred by
a one-sample two-tailed T-test. Multiple testing was accounted
for using the Benjamini–Hochberg procedure to control false
discovery rate with a significance threshold of 0.05 (q= 0.05) was
used.
Update and Expansion of iexGFMM_B2
To map all the potential biosynthetic pathways involved in
production of OMV metabolites to the combined Bt/mouse
metabolic model, the complete list of KEGG-mapped metabolites
found in either OMV sample was used in creating the updated
and extended model of the system. The KEGG database of
reactions (Kanehisa and Goto, 2000) was used as the set of
candidate reactions for the expansion of both the mouse and
Bt metabolic networks to fill gaps in the metabolic model. All
inferences concerning each metabolite considered in this work
can be found in Supplementary Table 1. All in silico GEM
reconstruction, modeling, and analysis was done in Python using
the COBRApy constraint-based modeling package (Ebrahim
et al., 2013), except for the application of FGF (Thiele et al., 2014)
which is implemented in the COBRA Toolbox v3.0 for MATLAB
(Heirendt et al., 2017).
The expanded integrated Bt/mouse GEM was based on model
iexGFMM_B2 (Heinken et al., 2013). Before expansion of the
model, several changes were made to allow the application of FGF
(see below) and to bring it up to date with current nomenclature.
Reactions and metabolites associated with the mouse cytosol
were moved from the generic cytosol compartment “c” into a
mouse-specific cytosol compartment “cm.” Similarly reactions
and metabolites associated with the close neighborhood of mouse
cells (the “extracellular” compartment) were moved from “e” to
“em.” All metabolite IDs were updated in line with their current
corresponding entries in the BiGG Models database (King et al.,
2016).
A new compartment named “OMV” with ID “o” was added
to the integrated model. When analysis was done in a specific
medium, the reactions corresponding to metabolites that were
not present in OMVs in that medium had their flux bounds
set to 0. To map the metabolites (with KEGG IDs) added to
the model, a set of correspondences between KEGG and BiGG
IDs was required. This was adapted from the dictionary that
accompanies the FGF software, with BiGG IDs updated and
duplicate entries removed. Further ID mappings were sought
manually for all KEGG IDs not included in the original dictionary
using MetaNetX (Ganter et al., 2013) and ChEBI. Although the
Bt model contains a “cytosol” compartment, it does not in fact
differentiate between cytosolic and periplasmic reactions, so the
Bt “cytosol” compartment is referred to as the Bt “cell” to make
this explicit. If the OMV metabolites were not found in either
the Bt cell (“c”) or the mouse cytosol (“cm”) they were added,
as well as to the OMV compartment (“o”) (Figure 2). For each
of these metabolites a pair of reactions were added, a transport
reaction from “c” to “o” and a transport reaction from “o” to
“cm.” These reactions were all set as irreversible to represent the
flow of material: packed into OMVs by Bt, then released and
taken up by mouse epithelial cells.
The inclusion of the OMV and other inferred reactions added
a large number of gaps to the model, whereby metabolites
were not producible or consumable in the mouse cell and/or
in the Bt cell. FGF (Thiele et al., 2014) was used to connect
up these metabolites to the rest of the metabolic network in
such a way as to add the fewest reactions possible (from a
complete list of KEGG reactions downloaded from the KEGG
database). In short, FGF constructs a global model by adding
a universal set of reactions (in this case all KEGG reactions)
to the input metabolic model, then runs the FASTCORE
algorithm (Vlassis et al., 2014) which iteratively computes
by linear optimization a flux-consistent model comprising of
all model reactions and a minimal set of added “universal
reactions.” This is a fast algorithm, but is limited by the
completeness and accuracy of the input metabolic network and
database.
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Since reaction downloads from KEGG do not contain
reversibility information, eQuilibrator (Noor et al., 2012) was
used to computationally estimate the reversibility of every KEGG
reaction. FGF was applied individually to the mouse cytosol and
the Bt cell to fill the gaps in both the biosynthetic pathways of the
OMV metabolites in the bacterium and their consequent uptake
and metabolism in the host cell.
For validation of all reactions that enabled the consumption
(and production) of these metabolites reversibility and
thermodynamically favorable direction in the model were
manually checked against the KEGG database. Where this
information contradicted the reversibility inference from
eQuilibrator the curated KEGG reversibility was used. To
find candidate enzymes for the reactions consuming these
metabolites in the mouse, the EC number of each one was
submitted to MouseCyc (Evsikov et al., 2009) to determine
whether an enzyme had previously been identified for
this reaction in mouse and if no enzyme was found, the
NCBI Gene database (NCBI Resource Coordinators, 2016)
was searched using the string “mus musculus [organism]
x.x.x.x” where “x.x.x.x” is the relevant EC number in
order to identify genes with a relevant annotation. Both
updated reversibility and inferred enzyme functions were
then added to the expanded model. If a gene found in this
way was already in the model (annotated as an enzyme
component catalyzing another reaction) an annotation
was appended to the existing annotation. The expanded
model is available in SBML format in the Supplementary
Material.
In Silico Metabolite Analysis
The ability of Bt and mouse to both produce and consume
each metabolite present in OMVs was determined by FBA.
To enable the analysis of each organism independently, the
other organism was blocked by setting the upper and lower
bounds of all relevant exchange reactions between the lumen
and that other organism to zero. Thus any metabolite would
have to be produced or consumed by the host or bacterial
organism, rather than be transported to or from the other
organism. All OMV reactions were also limited to 0 flux during
the producibility/consumability analysis to ensure assessment of
endogenous production and consumption. A source or sink for
each metabolite was added to the model enabling the distinction
between being able to produce and being able to consume the
metabolite; this source or sink reaction was set as the objective
and maximized. Adding a source reaction was used to test
whether the metabolite could be consumed and adding a sink
reaction was used to test whether it could be produced. Input
fluxes of metabolites representing food consumption were set
according to the in silico Western Diet detailed by Heinken et al.
(2013).
Assessment of the requirement for metabolite presence
(even if not in detectable amounts) in the in silico Bt cell
in iMM_BT_OMV was done using FBA. The Bt section of
the integrated model was used to model in vitro growth.
Exchange reactions for metabolites into the extracellular
space around Bt were set to a lower flux bound of
−100 g/gDW/h for all components of each medium. For
each metabolite inferred from the metabolomics data to
be imported by Bt in vitro a source reaction was created
for that metabolite with a small non-zero minimum flux,
to force the model solver only to return solutions that
fit the qualitative metabolite uptake profile seen in vitro.
Since the RM is not fully defined, but includes large
numbers of metabolites, the lower bounds of all exchange
reactions were set to −100 g/gDW/h for this medium. The
set of reactions containing each metabolite in the Bt cell
was then removed in turn, and the model optimized for
biomass growth. If the growth achieved by optimization
was below a cutoff of 0.1 h−1, then that metabolite was
inferred to be produced by necessity by Bt in the course of
growth.
Statistical Testing
Where enrichment analysis or comparisons were done for
any differences in attributes (presence, flow, consumability,
etc.) between two sets of metabolites, a χ2 test was used
to calculate a p-value for enrichment (the probability that
under the null hypothesis that the χ2 value would be
greater than or equal to the empirical χ2 value), and the
significance cutoff value used for all of these analyses was
p= 0.05.
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